www.nj.com

www.nj.com
Share

www.nj.com

 •  June 27

KENILWORTH -- The second-largest drugmaker in the United States is confirming it's been affected by a new and highly virulent outbreak of malicious data-scrambling software causing mass disruption across Europe. In a message sent using its verified Twitter account, Merck confirmed Tuesday that its computer network was "compromised" as part of the...

www.nj.com

 •  June 23

TRENTON -- Gov. Chris Christie's administration has joined a multi-state investigation into the pharmaceutical industry for the role it may have played in America's opioid abuse crisis, according to a report by The Record. At the same time, the state Attorney General's Office under Christie has also issued a subpoena to Johnson & Johnson, the New...

www.nj.com

 •  May 24

TRENTON -- Two former executives at a Monmouth County company that manufactures generic pharmaceuticals agreed to cooperate in a multi-state investigation into whether multiple companies in the industry colluded to inflate drug prices, the state Attorney General's Office announced Wednesday. Jason Malek, the ex-president of Heritage Pharmaceuticals...

www.nj.com

 •  April 24

A New Jersey drug manufacturer is recalling bottles of one of its products because of a labeling error that provided people with pills that are double the expected dose. C.O. Truxton, Inc. has issued a nationwide recall for bottles of its 15 mg Phenobarbital tablets because they may actually contain 30 mg tablets. The Bellmawr-based company said it...

www.nj.com

 •  March 9

A national clinical trial for an unorthodox drug to treat a cancer that strikes very young children now has openings in New Jersey, thanks to a foundation. The Phase 2 trial for a medication to treat neuroblastoma recently added Hackensack University Medical Center as a research site - one of only two East Coast research sites between Connecticut...

www.nj.com

 •  February 14

A study released Tuesday showed Americans are shifting to generic drugs and away from pricier brand name medicines, stabilizing overall medical spending, USA Today reported. The use of generic medications jumped 8 percent last year, while the use of brand name prescription medications dropped by 20.7 percent, according to Health Care Cost...